Tag Stergios J. Moschos

Adjuvant Therapy for Cutaneous Melanoma

Key Points Chemotherapy regimens, non-specific immunostimulants and vaccines alone have failed to show any survival benefit in the adjuvant setting. High-dose interferon-α2b is the only approved drug shown to improve relapse-free and overall survival in large multi-institutional randomized controlled trials…